Citations (317)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Tomislav Majić, Lasse Brandt & Christiane Montag. (2022) Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study. Journal of Psychoactive Drugs 54:4, pages 378-385.
Read now
Read now
Carina S Peritore. (2022) The Promise of Psychedelic Research. Future Drug Discovery 4:1.
Read now
Read now
Rafael Guimarães dos Santos, José Carlos Bouso, Juliana Mendes Rocha, Giordano Novak Rossi & Jaime E Hallak. (2021) The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. Risk Management and Healthcare Policy 14, pages 901-910.
Read now
Read now
Matthew J. Baggott, Kathleen J. Garrison, Jeremy R. Coyle, Gantt P. Galloway, Allan J. Barnes, Marilyn A. Huestis & John E. Mendelson. (2019) Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. Journal of Psychoactive Drugs 51:2, pages 108-117.
Read now
Read now
Alicia L. Danforth. (2019) Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults. Journal of Psychoactive Drugs 51:2, pages 146-154.
Read now
Read now
Jagriti Narang, Chaitali Singhal, Manika Khanuja, Ashish Mathur, Akshay Jain & C. S. Pundir. (2018) Hydrothermally synthesized zinc oxide nanorods incorporated on lab-on-paper device for electrochemical detection of recreational drug. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1586-1593.
Read now
Read now
Albert Garcia-Romeu & William A. Richards. (2018) Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry 30:4, pages 291-316.
Read now
Read now
Torsten Passie & Udo Benzenhöfer. (2016) The History of MDMA as an Underground Drug in the United States, 1960–1979. Journal of Psychoactive Drugs 48:2, pages 67-75.
Read now
Read now
Sara B Taylor, Candace R Lewis & M Foster Olive. (2013) The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Substance Abuse and Rehabilitation 4, pages 29-43.
Read now
Read now
Jerrold S Meyer. (2013) 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation 4, pages 83-99.
Read now
Read now
Céline Eiden, Philippe Cathala, Nicolas Fabresse, Yves Galea, Jean-Claude Mathieu-Daudé, Eric Baccino & Hélène Peyrière. (2013) A Case of Drug-Facilitated Sexual Assault Involving 3,4-methylene-dioxy-methylamphetamine. Journal of Psychoactive Drugs 45:1, pages 94-97.
Read now
Read now
Andreas Schindler, Rainer Thomasius, Kay Petersen & Peter-Michael Sack. (2009) Heroin as an attachment substitute? Differences in attachment representations between opioid, ecstasy and cannabis abusers. Attachment & Human Development 11:3, pages 307-330.
Read now
Read now
Micheline Duterte, Camille Jacinto, Paloma Sales & Sheigla Murphy. (2009) What's in a Label? Ecstasy Sellers' Perceptions of Pill Brands. Journal of Psychoactive Drugs 41:1, pages 27-37.
Read now
Read now
José
Carlos Bouso, Rick Doblin, Magí Farré, Miguel
Ángel Alcázar & Gregorio Gómez-Jarabo. (2008) MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder. Journal of Psychoactive Drugs 40:3, pages 225-236.
Read now
Read now
N. Shima, M. Katagi, H. Kamata, K. Zaitsu, T. Kamata, M. Nishikawa, A. Miki, H. Tsuchihashi, T. Sakuma & N. Nemoto. (2008) Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Xenobiotica 38:3, pages 314-324.
Read now
Read now
Harris Friedman. (2006) The Renewal of Psychedelic Research: Implications for Humanistic and Transpersonal Psychology. The Humanistic Psychologist 34:1, pages 39-58.
Read now
Read now
MichaelG. Vaughn, MatthewO. Howard & MaryP. Curtis. (2005) Is Ecstasy (MDMA) Use Associated with Symptoms of Anxiety or Depression Among Incarcerated Juvenile Offenders?. Journal of Evidence-Based Social Work 2:3-4, pages 19-34.
Read now
Read now
D Springer, R. F Staack, L. D Paul, T Kraemer & H. H Maurer. (2005) Identification of cytochrome P450 enzymes involved in the metabolism of 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes. Xenobiotica 35:3, pages 227-237.
Read now
Read now
Jane Carlisle Maxwell. (2005) Party Drugs: Properties, Prevalence, Patterns, and Problems. Substance Use & Misuse 40:9-10, pages 1203-1240.
Read now
Read now
Joachim D. K. Uys, Joachim D. K. Uys & Raymond J. M. Niesink. (2005) Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature. Drug and Alcohol Review 24:4, pages 359-368.
Read now
Read now
Deirdre Butler & George
G. Guilbault. (2004) Analytical Techniques for Ecstasy. Analytical Letters 37:10, pages 2003-2030.
Read now
Read now
FranzX. Vollenweider, MatthiasE. Liechti, Alex Gamma, George Greer & Mark Geyer. (2002) Acute Psychological and Neurophysiological Effects of MDMA in Humans. Journal of Psychoactive Drugs 34:2, pages 171-184.
Read now
Read now
AlanaR. Pentney. (2001) An Exploration of the History and Controversies Surrounding MDMA and MDA. Journal of Psychoactive Drugs 33:3, pages 213-221.
Read now
Read now
ThomasJ. Riedlinger & JuneE. Riedlinger. (1994) Psychedelic and Entactogenic Drugs in the Treatment of Depression. Journal of Psychoactive Drugs 26:1, pages 41-55.
Read now
Read now
Articles from other publishers (293)
Brian A. Baldo. (2024) The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns. Archives of Toxicology.
Crossref
Crossref
Mark A. Geyer. (2024) A Brief Historical Overview of Psychedelic Research. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 9:5, pages 464-471.
Crossref
Crossref
Shimeng Duan, Haiou Chen, Anyun Xu, Ying He, Meng Li, Ru Zhang, Ruilin Zhang & Huiping Bai. (2024) A simple polyarginine membrane electrochemical sensor for the determination of MDMA and MDA. Analytical Biochemistry 688, pages 115478.
Crossref
Crossref
Bill Brennan & Alex Belser. 2024. EMBARK Psychedelic Therapy for Depression. EMBARK Psychedelic Therapy for Depression.
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow & Rachel Yehuda. (2024) The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 22:4, pages 636-735.
Crossref
Crossref
F. Dellanoce, Z. Dubus, M. Vidal, C. Vigourt & T. Rabeyron. (2024) Une nouvelle prise en charge innovante dans le traitement des troubles de stress post-traumatique : la thérapie assistée par MDMA, approche historique et analyse des protocoles actuels. Pratiques Psychologiques 30:1, pages 37-56.
Crossref
Crossref
Navoda Jayakodiarachchi, Mallory A. Maurer, Daniel C. Schultz, Cayden J. Dodd, Analisa Thompson Gray, Hyekyung P. Cho, Olivier Boutaud, Carrie K. Jones, Craig W. Lindsley & Aaron M. Bender. (2024) Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists. ACS Medicinal Chemistry Letters 15:2, pages 302-309.
Crossref
Crossref
Negar Sayrafizadeh, Nicole Ledwos, M. Ishrat Husain & David J. Castle. (2024) Aggressive behaviours associated with MDMA and psychedelics: a narrative review. Acta Neuropsychiatrica, pages 1-13.
Crossref
Crossref
Boris D. Heifets & David E. Olson. (2023) Therapeutic mechanisms of psychedelics and entactogens. Neuropsychopharmacology 49:1, pages 104-118.
Crossref
Crossref
Roy Gerona. 2024. Designer Drugs. Designer Drugs
65
98
.
Ava Wexler, Alexandra Dubinskaya, Julie Suyama, Barry R Komisaruk, Jennifer Anger & Karyn Eilber. (2024) Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles. Sexual Medicine Reviews 12:1, pages 26-34.
Crossref
Crossref
Richard A. Glennon & Mal̵gorzata Dukat. (2023) α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant. ACS Pharmacology & Translational Science 6:12, pages 1780-1789.
Crossref
Crossref
Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D. Brandt, Torsten Passie, Matthias E. Liechti & Volker Auwärter. (2023) Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study. Drug Testing and Analysis.
Crossref
Crossref
Aaron S. Wolfgang & Charles W. Hoge. (2023) Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations. Current Psychiatry Reports 25:10, pages 513-532.
Crossref
Crossref
Trent D. Emerick, Thomas J. MartinDouglas G. Ririe. (2023) Perioperative Considerations for Patients Exposed to Psychostimulants. Anesthesia & Analgesia 137:3, pages 474-487.
Crossref
Crossref
Harpreet KaurSedat KarabulutJames W. GauldStephen A. FagotKalee N. HollowayHannah E. ShawWilliam E. Fantegrossi. (2023) Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder. Psychedelic Medicine 1:3, pages 166-185.
Crossref
Crossref
Oluwasesan Adegoke & Niamh Nic Daeid. (2023) Ultralow detection of 3,4-methylenedioxymethylamphetamine using an immunofluorescence nanoconjugate of heavy metal-free alloyed quantum dots and NiCeFe3O4 magnetic nanoparticles. Journal of Photochemistry and Photobiology A: Chemistry 442, pages 114803.
Crossref
Crossref
Scott R. Walker, Glenn A. Pullella, Matthew J. Piggott & Peter J. Duggan. (2023) Introduction to the chemistry and pharmacology of psychedelic drugs. Australian Journal of Chemistry 76:5, pages 236-257.
Crossref
Crossref
Benjamin R. LewisKevin Byrne. (2023) A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. FOCUS 21:3, pages 247-256.
Crossref
Crossref
Uwe Herwig, Lea Mertens, Sergio Pérez Rosal, Gabriele Koller, Andrea Jungaberle, Stefan Borgwardt & Gerhard Gründer. (2023) Psychedelika in der Psychiatrie – Entwicklungen und die
Stellung in Deutschland. Fortschritte der Neurologie · Psychiatrie 91:07/08, pages 311-318.
Crossref
Crossref
Bryan L. RothRyan H. Gumpper. (2023) Psychedelics as Transformative Therapeutics. American Journal of Psychiatry 180:5, pages 340-347.
Crossref
Crossref
Sivan Schipper, Kabir Nigam, Vanessa Piechotta, Michael Ljuslin, Yvan Beaussant, Guido Schwarzer & Christopher Boehlke. (2022) Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care. Cochrane Database of Systematic Reviews 2022:11.
Crossref
Crossref
Jack E. Henningfield, Marion A. Coe, Roland R. Griffiths, Sean J. Belouin, Ann Berger, Allison R. Coker, Sandra D. Comer, David J. Heal, Peter S. Hendricks, Charles D. Nichols, Frank Sapienza, Frank J. Vocci & Farah Z. Zia. (2022) Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology 218, pages 109220.
Crossref
Crossref
Jenna M. TraynorDaniel E. RobertsStephen RossRichard ZeifmanLois Choi-Kain. (2022) MDMA-Assisted Psychotherapy for Borderline Personality Disorder. FOCUS 20:4, pages 358-367.
Crossref
Crossref
Devon Stoliker, Gary F. Egan, Karl J. Friston & Adeel Razi. (2022) Neural Mechanisms and Psychology of Psychedelic Ego Dissolution. Pharmacological Reviews 74:4, pages 876-917.
Crossref
Crossref
Niloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, Yena Lee, Joshua D. Rosenblat, Kayla M. Teopiz, Leanna M. W. Lui, Mehala Subramaniapillai, Kangguang Lin, Flora Nasri, Nelson Rodrigues, Hartej Gill, Orly Lipsitz, Bing Cao, Roger Ho, David Castle & Roger S. McIntyre. (2022) A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. CNS Drugs 36:10, pages 1031-1047.
Crossref
Crossref
William Barone, Michiko Mitsunaga-Whitten, Lia Osunfunláyò Blaustein, Phillip Perl, Marisa Swank & Thomas Cody Swift. (2022) Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness. Frontiers in Psychiatry 13.
Crossref
Crossref
Ryan L. Henner, Matcheri S. Keshavan & Kevin P. Hill. (2022) Review of otential sychedelic reatments for PTSD. Journal of the Neurological Sciences 439, pages 120302.
Crossref
Crossref
Emma C. Gordon. (2022) Trust and Psychedelic Moral Enhancement. Neuroethics 15:2.
Crossref
Crossref
V. L. Matrenitsky. (2022) РЕНЕСАНС ПСИХОДЕЛІЧНОЇ ТЕРАПІЇ ТА ЇЇ ЗНАЧЕННЯ ДЛЯ УКРАЇНИ. Likarska sprava:3-4, pages 37-59.
Crossref
Crossref
William Brennan & Alexander B. Belser. (2022) Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Frontiers in Psychology 13.
Crossref
Crossref
Karolina E. Kolaczynska, Paula Ducret, Daniel Trachsel, Marius C. Hoener, Matthias E. Liechti & Dino Luethi. (2022) Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: ,α-DEPEA and DPIA. European Neuropsychopharmacology 59, pages 9-22.
Crossref
Crossref
Jessica L. Sharp & Mark A. Smith. (2022) The Effects of Drugs on Behavior Maintained by Social Contact: Role of Monoamines in Social Reinforcement. Frontiers in Behavioral Neuroscience 15.
Crossref
Crossref
Haobo Sun, Jingliang Liu, Yunliang Qiu, Jinming Kong & Xueji Zhang. (2022) High sensitive electrochemical methamphetamine detection in serum and urine via atom transfer radical polymerization signal amplification. Talanta 238, pages 123026.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2022. Neuropathologie des Drogenmissbrauchs. Neuropathologie des Drogenmissbrauchs
23
90
.
Alessio Fiorentini, Filippo Cantù, Camilla Crisanti, Guido Cereda, Lucio Oldani & Paolo Brambilla. (2021) Substance-Induced Psychoses: An Updated Literature Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Kacper Lukasiewicz, Jacob J. Baker, Yi Zuo & Ju Lu. (2021) Serotonergic Psychedelics in Neural Plasticity. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Ángel A. Islas, Laura G. Moreno & Thomas Scior. (2021) Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT). Heliyon 7:8, pages e07784.
Crossref
Crossref
Erich Studerus, Patrick Vizeli, Samuel Harder, Laura Ley & Matthias E Liechti. (2021) Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies. Journal of Psychopharmacology 35:5, pages 556-565.
Crossref
Crossref
Hans Emanuel Oeri. (2020) Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of Psychopharmacology 35:5, pages 512-536.
Crossref
Crossref
F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman & P. Anantha Reddy. (2020) Designer drugs: a medicinal chemistry perspective (II). Annals of the New York Academy of Sciences 1489:1, pages 48-77.
Crossref
Crossref
Danilo De Gregorio, Argel Aguilar-Valles, Katrin H. Preller, Boris Dov Heifets, Meghan Hibicke, Jennifer Mitchell & Gabriella Gobbi. (2021) Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. The Journal of Neuroscience 41:5, pages 891-900.
Crossref
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Crossref
Jessica Lochtenberg, Ari Kirshenbaum & Matthew W. Johnson. (2021) Pharmacological assistance for psychotherapy. Emerging Trends in Drugs, Addictions, and Health 1, pages 100017.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse
23
87
.
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Carl A Roberts, Isaac Osborne-Miller, Jon Cole, Suzanne H Gage & Paul Christiansen. (2020) Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use. Journal of Psychopharmacology 34:9, pages 999-1007.
Crossref
Crossref
Lena S. Jia & Jessica A. Gold. (2020) Hallucinogen Use in College Students: Current Trends and Consequences of Use. Current Psychopharmacology 9:2, pages 115-127.
Crossref
Crossref
Ji Hyun Lee, Ok Rim Park, Suresh Mandava, Jemin Kim, Jaun Koo, Jongkook Lee & Hoil Kang. (2020) Identification of a new M-ALPHA analog and MDMA in an illegal health product. Forensic Science International 313, pages 110332.
Crossref
Crossref
Marija Ilic, Julian Maier, Marion Holy, Kathrin Jaentsch, Matthias E. Liechti, Gert Lubec, Michael H. Baumann, Harald H. Sitte & Dino Luethi. (2020) Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters. Frontiers in Pharmacology 11.
Crossref
Crossref
Friederike Holze, Patrick Vizeli, Felix Müller, Laura Ley, Raoul Duerig, Nimmy Varghese, Anne Eckert, Stefan Borgwardt & Matthias E. Liechti. (2019) Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects. Neuropsychopharmacology 45:3, pages 462-471.
Crossref
Crossref
Adam L. Halberstadt & David E. Nichols. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
843
863
.
Erin Kaleta. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory
227
238
.
Mashal Khan & Anil Thomas. 2020. Absolute Addiction Psychiatry Review. Absolute Addiction Psychiatry Review
205
230
.
Milena Jadrijević-Mladar Takač, Joao Daniel Casimiro Magina & Tin Takač. (2019) Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study. Acta Pharmaceutica 69:4, pages 563-584.
Crossref
Crossref
Patrick Vizeli & Matthias E. Liechti. (2019) No Influence of Dopamine System Gene Variations on Acute Effects of MDMA. Frontiers in Psychiatry 10.
Crossref
Crossref
Ruff Joseph Macale Cajanding. (2019) MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge. AACN Advanced Critical Care 30:3, pages 232-248.
Crossref
Crossref
Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson & Rick Doblin. (2019) MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236:9, pages 2735-2745.
Crossref
Crossref
M. P. García‐Pardo, J. Miñarro, M. Llansola, V. Felipo & M. A. Aguilar. (2018)
Role of
NMDA
and
AMPA
glutamatergic receptors in the effects of social defeat on the rewarding properties of
MDMA
in mice
. European Journal of Neuroscience 50:3, pages 2623-2634.
Crossref
Crossref
Yoshimi Peck, Alan R. Clough, Peter N. Culshaw & Michael J. Liddell. (2019) Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia. Drug and Alcohol Dependence 201, pages 49-57.
Crossref
Crossref
Madeline M. Pantoni & Stephan G. Anagnostaras. (2019) Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose. Pharmacological Reviews 71:3, pages 413-449.
Crossref
Crossref
Rosa A.S. Couto, Séfora S. Costa, Bassim MounssefJr.Jr., João G. Pacheco, Eduarda Fernandes, Félix Carvalho, Cecília M.P. Rodrigues, Cristina Delerue-Matos, Ataualpa A.C. Braga, Luís Moreira Gonçalves & M. Beatriz Quinaz. (2019) Electrochemical sensing of ecstasy with electropolymerized molecularly imprinted poly(o-phenylenediamine) polymer on the surface of disposable screen-printed carbon electrodes. Sensors and Actuators B: Chemical 290, pages 378-386.
Crossref
Crossref
Ottavia Dipasquale, Pierluigi Selvaggi, Mattia Veronese, Anthony S. Gabay, Federico Turkheimer & Mitul A. Mehta. (2019) Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA. NeuroImage 195, pages 252-260.
Crossref
Crossref
Ben Sessa, Laurie Higbed & David Nutt. (2019) A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy. Frontiers in Psychiatry 10.
Crossref
Crossref
Michaela Pettie, Alana Oakly, David N Harper & Bart A Ellenbroek. (2019) A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA. Journal of Psychopharmacology 33:3, pages 355-363.
Crossref
Crossref
Charlotte Martial, Héléna Cassol, Vanessa Charland-Verville, Carla Pallavicini, Camila Sanz, Federico Zamberlan, Rocío Martínez Vivot, Fire Erowid, Earth Erowid, Steven Laureys, Bruce Greyson & Enzo Tagliazucchi. (2019) Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. Consciousness and Cognition 69, pages 52-69.
Crossref
Crossref
Jeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu & Jodi L. Smith. 2019. Neuropsychotherapeutics. Neuropsychotherapeutics
47
96
.
Euphrosyne Gouzoulis-Mayfrank, Tomislav Majić & Michael Schaub. 2019. Suchtmedizin. Suchtmedizin
203
221
.
Federico Zamberlan, Camila Sanz, Rocío Martínez Vivot, Carla Pallavicini, Fire Erowid, Earth Erowid & Enzo Tagliazucchi. (2018) The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines. Frontiers in Integrative Neuroscience 12.
Crossref
Crossref
Ben Sessa. (2018) Why MDMA therapy for alcohol use disorder? And why now?. Neuropharmacology 142, pages 83-88.
Crossref
Crossref
Bruce K. Cassels & Patricio Sáez-Briones. (2018) Dark Classics in Chemical Neuroscience: Mescaline. ACS Chemical Neuroscience 9:10, pages 2448-2458.
Crossref
Crossref
Lee E. Dunlap, Anne M. Andrews & David E. Olson. (2018) Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine. ACS Chemical Neuroscience 9:10, pages 2408-2427.
Crossref
Crossref
Brian D. Earp. (2018) Psychedelic Moral Enhancement. Royal Institute of Philosophy Supplement 83, pages 415-439.
Crossref
Crossref
Eric Edsinger & Gül Dölen. (2018) A Conserved Role for Serotonergic Neurotransmission in Mediating Social Behavior in Octopus. Current Biology 28:19, pages 3136-3142.e4.
Crossref
Crossref
Michelle S Thiessen, Zach Walsh, Brian M Bird & Adele Lafrance. (2018) Psychedelic use and intimate partner violence: The role of emotion regulation. Journal of Psychopharmacology 32:7, pages 749-755.
Crossref
Crossref
M.P. García-Pardo, J. Miñarro & M.A. Aguilar. (2018) Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice. Behavioural Brain Research 347, pages 57-60.
Crossref
Crossref
Francesca Romana Rizzo, Mauro Federici & Nicola Biagio Mercuri. (2018) 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition. Neuroscience 377, pages 69-76.
Crossref
Crossref
Mercedes Martín-López, Ana T. Muela, María Cavas & José Francisco Navarro. (2018) Effects of para-methoxyamphetamine (PMA) on agonistic encounters between male mice. Pharmacology Biochemistry and Behavior 167, pages 9-16.
Crossref
Crossref
Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire, Matthew B. Young & Leonard L. Howell. (2017) (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology 235:2, pages 377-392.
Crossref
Crossref
Allison A. Feduccia, Julie Holland & Michael C. Mithoefer. (2017) Progress and promise for the MDMA drug development program. Psychopharmacology 235:2, pages 561-571.
Crossref
Crossref
Ben Sessa. (2017) The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant. Psychopharmacology 235:2, pages 551-560.
Crossref
Crossref
Camila Sanz, Federico Zamberlan, Earth Erowid, Fire Erowid & Enzo Tagliazucchi. (2018) The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports. Frontiers in Neuroscience 12.
Crossref
Crossref
Jon E. Sprague, Christopher L. Riley & Edward M. Mills. 2018. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II
623
633
.
Serge Weis & Andreas Büttner. 2018. Neuropathology. Neuropathology
181
192
.
Maximilian von Heyden. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
517
535
.
Katherine Hendy. 2018. Plant Medicines, Healing and Psychedelic Science. Plant Medicines, Healing and Psychedelic Science
151
166
.
Matteo Lazzaretti, Gian Mario Mandolini, Alfredo Carlo Altamura & Paolo Brambilla. 2018. Hallucinations in Psychoses and Affective Disorders. Hallucinations in Psychoses and Affective Disorders
17
31
.
Matteo Lazzaretti, Gian Mario Mandolini, Alfredo Carlo Altamura & Paolo Brambilla. 2018. Hallucinations in Psychoses and Affective Disorders. Hallucinations in Psychoses and Affective Disorders
3
16
.
Linda D. Simmler & Matthias E. Liechti. 2018. New Psychoactive Substances. New Psychoactive Substances
143
164
.
María Pilar García-Pardo, Jose Enrique De la Rubia Ortí & Maria Asunción Aguilar Calpe. (2017) Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents. Neurobiology of Learning and Memory 146, pages 1-11.
Crossref
Crossref
Sean B. Dolan, Michael J. Forster & Michael B. Gatch. (2017) Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine. Drug and Alcohol Dependence 180, pages 39-45.
Crossref
Crossref
Ishan C Walpola, Timothy Nest, Leor Roseman, David Erritzoe, Amanda Feilding, David J Nutt & Robin L Carhart-Harris. (2017) Altered Insula Connectivity under MDMA. Neuropsychopharmacology 42:11, pages 2152-2162.
Crossref
Crossref
Janis Phelps. (2017) Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology 57:5, pages 450-487.
Crossref
Crossref
Matthias Forstmann & Christina Sagioglou. (2017) Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Journal of Psychopharmacology 31:8, pages 975-988.
Crossref
Crossref
M.P. García-Pardo, M. Rodríguez-Arias, J. Miñarro & M.A. Aguilar. (2017) Role of nitric oxide pathway in the conditioned rewarding effects of MDMA in mice. Behavioural Brain Research 330, pages 75-77.
Crossref
Crossref
Ben Sessa. (2017) Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective. Neurotherapeutics 14:3, pages 741-749.
Crossref
Crossref
Ben Sessa. (2017) Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?. Journal of Psychedelic Studies 1:1, pages 1-9.
Crossref
Crossref
Maryam Abbasian, Mahdi Balali-Mood, Hossein Salar Amoli & Akram Masoumi. (2016) A new solid-phase microextraction fiber for separation and determination of methamphetamines in human urine using sol–gel technique. Journal of Sol-Gel Science and Technology 81:1, pages 247-260.
Crossref
Crossref
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1521
1570
.
Maximilian von Heyden. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
26
.
Nicholas J. Connors & Robert S. Hoffman. 2017. Critical Care Toxicology. Critical Care Toxicology
1413
1438
.
Lisa E. Baker. 2018. Behavioral Neurobiology of Psychedelic Drugs. Behavioral Neurobiology of Psychedelic Drugs
201
219
.
Anya K Bershad, Melissa A Miller, Matthew J Baggott & Harriet de Wit. (2016) The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?. Journal of Psychopharmacology 30:12, pages 1248-1258.
Crossref
Crossref
Evan J. KyzarAllan V. Kalueff. (2016) Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Zebrafish 13:5, pages 379-390.
Crossref
Crossref
Tomáš Páleníček, Eva Lhotková, Monika Žídková, Marie Balíková, Martin Kuchař, Michal Himl, Petra Mikšátková, Martin Čegan, Karel Valeš, Filip Tylš & Rachel R. Horsley. (2016) Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 69, pages 49-59.
Crossref
Crossref
Vicka Rael CoreyVincent D. PisanoJohn H. Halpern. (2016) Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting. Journal of Nervous & Mental Disease 204:7, pages 519-523.
Crossref
Crossref
Michael C Mithoefer, Charles S Grob & Timothy D Brewerton. (2016) Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3:5, pages 481-488.
Crossref
Crossref
Matthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, Kathleen J Garrison, Gantt P Galloway & John E Mendelson. (2016) Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. Journal of Psychopharmacology 30:4, pages 378-387.
Crossref
Crossref
F. Mueller, C. Lenz, M. Steiner, P.C. Dolder, M. Walter, U.E. Lang, M.E. Liechti & S. Borgwardt. (2016) Neuroimaging in moderate MDMA use: A systematic review. Neuroscience & Biobehavioral Reviews 62, pages 21-34.
Crossref
Crossref
Stephanie M Woo & Carolyn Keatinge. 2016. Diagnosis and Treatment of Mental Disorders Across the Lifespan. Diagnosis and Treatment of Mental Disorders Across the Lifespan
957
1168
.
Sébastien Ballesta, Gilles Reymond, Matthieu Pozzobon & Jean-René Duhamel. (2016) Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis). PLOS ONE 11:2, pages e0147136.
Crossref
Crossref
Thomas S. Ray. (2016) Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method. Medical Hypotheses 87, pages 48-60.
Crossref
Crossref
Alicia L. Danforth, Christopher M. Struble, Berra Yazar-Klosinski & Charles S. Grob. (2016) MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 237-249.
Crossref
Crossref
Berit Brogaard & Dimitria Electra Gatzia. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
890
905
.
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
51
.
Nicholas J. Connors & Robert S. Hoffman. 2016. Critical Care Toxicology. Critical Care Toxicology
1
26
.
Shawn M. Aarde & Michael A. Taffe. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
145
164
.
Esa R. Korpi, Bjørnar den Hollander, Usman Farooq, Elena Vashchinkina, Ramamoorthy Rajkumar, David J. Nutt, Petri Hyytiä & Gavin S. Dawe. (2015) Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacological Reviews 67:4, pages 872-1004.
Crossref
Crossref
Maria C. Blanco-Gandía, Ana Mateos-García, Maria P. García-Pardo, Sandra Montagud-Romero, Marta Rodríguez-Arias, José Miñarro & María A. Aguilar. (2015) Effect of drugs of abuse on social behaviour. Behavioural Pharmacology 26:6, pages 541-570.
Crossref
Crossref
Matthew J Baggott, Matthew G Kirkpatrick, Gillinder Bedi & Harriet de Wit. (2015) Intimate insight: MDMA changes how people talk about significant others. Journal of Psychopharmacology 29:6, pages 669-677.
Crossref
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Crossref
Tomislav Majić, Timo T Schmidt & Jürgen Gallinat. (2015) Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?. Journal of Psychopharmacology 29:3, pages 241-253.
Crossref
Crossref
Alexander S. Dawson. (2015)
Salvador Roquet, María Sabina, and the Trouble with
Jipis
. Hispanic American Historical Review 95:1, pages 103-133.
Crossref
Crossref
Débora González, Marta Torrens & Magí Farré. (2015) Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Ilung Seol, Dongkoo Lim, Jaesin Lee & Heejin Yang. (2014) Comparative studies on behavioral neurochemical effects of N,α-diethylphenethylamine and methamphetamine in rats. Forensic Toxicology 33:1, pages 77-83.
Crossref
Crossref
Bruce E. Blough, Antonio Landavazo, Ann M. Decker, John S. Partilla, Michael H. Baumann & Richard B. Rothman. (2014) Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology 231:21, pages 4135-4144.
Crossref
Crossref
Maria P. García-Pardo, Marta Rodríguez-Arias, Concepcion Maldonado, Carmen Manzanedo, Jose Miñarro & Maria A. Aguilar. (2014) Effects of acute social stress on the conditioned place preference induced by MDMA in adolescent and adult mice. Behavioural Pharmacology 25:5 and 6, pages 532-546.
Crossref
Crossref
Jussara Amato, Nunzia Iaccarino, Bruno Pagano, Maria Maglieri, Guido Persico, Roberto Russo, Carmen De Caro, Antonio Calignano, Ettore Novellino & Antonio Randazzo. (2014) Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking. Forensic Toxicology 32:2, pages 311-316.
Crossref
Crossref
Amy J. Eshleman, Michael J. Forster, Katherine M. Wolfrum, Robert A. Johnson, Aaron Janowsky & Michael B. Gatch. (2013) Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology 231:5, pages 875-888.
Crossref
Crossref
Aaron R. Mangold, Thomas P Bravo, Stephen J. Traub, Steven A. Maher & Christopher A. Lipinski. (2014) Flashback phenomenon and residual neurological deficits after the use of "bath salt" 3, 4- methylenedioxypyrovalerone. World Journal of Emergency Medicine 5:1, pages 63.
Crossref
Crossref
Andreas Büttner. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
169
202
.
Jaesin Lee, Bastiaan J. Venhuis, Sewoong Heo, Hyeyoung Choi, Ilung Seol & Eunmi Kim. (2013) Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet. Forensic Toxicology 32:1, pages 148-153.
Crossref
Crossref
Andrew C. Parrott. (2013) Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. Human Psychopharmacology: Clinical and Experimental 28:4, pages 289-307.
Crossref
Crossref
Laurent Karila, Aymeric Petit, Rim Zarmdini, Sarah Coscas, William Lowenstein & Michel Reynaud. (2013) Consommation de tabac et trouble lié à l’usage de substances illicites : que devrions-nous faire ?. La Presse Médicale 42:5, pages 795-805.
Crossref
Crossref
Jaesin Lee, Sanggil Choe, Hyeyoung Choi, Sewoong Heo, Eunmi Kim, Hyunju Kim, Eunjung Bang & Heesun Chung. (2012) Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug?. Forensic Toxicology 31:1, pages 54-58.
Crossref
Crossref
Tomáš Páleníček, Michaela Fujáková, Martin Brunovský, Jiří Horáček, Ingmar Gorman, Marie Balíková, Lukáš Rambousek, Kamila Syslová, Petr Kačer, Petr Zach, Věra Bubeníková-Valešová, Filip Tylš, Anna Kubešová, Jana Puskarčíková & Cyril Höschl. (2012) Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology 225:1, pages 75-93.
Crossref
Crossref
Adam L. Halberstadt, Mahálah R. Buell, Diana L. Price & Mark A. Geyer. (2012) Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacology Biochemistry and Behavior 102:1, pages 88-94.
Crossref
Crossref
Janet K. Coller & Mark R. Hutchinson. (2012) Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacology & Therapeutics 134:2, pages 219-245.
Crossref
Crossref
Matthew D. Zuckerman & Edward W. Boyer. (2012) HIV and club drugs in emerging adulthood. Current Opinion in Pediatrics 24:2, pages 219-224.
Crossref
Crossref
Rowan P. Ogeil, David J. Kennaway, Mark D. Salkeld, Shantha M. W. Rajaratnam & Jillian H. Broadbear. (2011) MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei. Psychopharmacology 220:4, pages 835-843.
Crossref
Crossref
Donald G. BarcelouxNicholas A. Buckley. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
126
155
.
Donald G. BarcelouxBrandon Wills & Timothy Erickson. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
156
192
.
Andreas Schindler, Peter-Michael Sack & Rainer Thomasius. (2012) Bindungsmuster von Cannabis- und Ecstasykonsumenten. SUCHT 58:1, pages 45-53.
Crossref
Crossref
K.S. Murnane, H.L. Kimmel, K.C. Rice & L.L. Howell. (2012) The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine (“ecstasy”): A concurrent microdialysis and plasma analysis study. Hormones and Behavior 61:2, pages 181-190.
Crossref
Crossref
Hugo Lövheim. (2012) A new three-dimensional model for emotions and monoamine neurotransmitters. Medical Hypotheses 78:2, pages 341-348.
Crossref
Crossref
Rowan P OGEIL, Shantha MW RAJARATNAM & Jillian H BROADBEAR. (2012) Ecstasy and sleep disturbance: Progress towards elucidating a role for the circadian system. Sleep and Biological Rhythms 10:1, pages 3-13.
Crossref
Crossref
M.-H. Ghysel-Laporte, P. Sibille & N. Milan. 2012. Traité De Toxicologie Médico-judiciaire. Traité De Toxicologie Médico-judiciaire
455
505
.
Tibor M. Brunt & Raymond J.M. Niesink. (2011) The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison. Drug Testing and Analysis 3:9, pages 621-634.
Crossref
Crossref
Laurent Karila & Michel Reynaud. (2010) GHB and synthetic cathinones: clinical effects and potential consequences. Drug Testing and Analysis 3:9, pages 552-559.
Crossref
Crossref
Elena Puerta & Norberto Aguirre. (2011) Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation. Pharmaceuticals 4:7, pages 992-1018.
Crossref
Crossref
Akira Namera, Akihiro Nakamoto, Takeshi Saito & Masataka Nagao. (2011) Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review. Forensic Toxicology 29:1, pages 1-24.
Crossref
Crossref
Styliani Vlachou & Athina Markou. 2011. Animal Models of Drug Addiction. Animal Models of Drug Addiction
3
56
.
K. S. Murnane, W. E. Fantegrossi, J. R. Godfrey, M. L. Banks & L. L. Howell. (2010) Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics 334:2, pages 642-650.
Crossref
Crossref
Winnie Jeng & Peter G. Wells. (2010) Reduced 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Initiated Oxidative DNA Damage and Neurodegeneration in Prostaglandin H Synthase-1 Knockout Mice. ACS Chemical Neuroscience 1:5, pages 366-380.
Crossref
Crossref
Déborah Hirt, Julien Fonsart, Marie-Claude Menet, Marcel Debray, Florence Noble, Xavier Declèves & Jean-Michel Scherrmann. (2010) Population Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and Main Metabolites in Rats. Toxicological Sciences 114:1, pages 38-47.
Crossref
Crossref
X. Q. Li, C. E. Uboh, L. R. Soma, F. Y. Guan, Y. W. You, M. C. Kahler, J. A. Judy, Y. Liu & J. W. Chen. (2010) Simultaneous separation and confirmation of amphetamine and related drugs in equine plasma by non‐aqueous capillary‐electrophoresis‐tandem mass spectrometry. Drug Testing and Analysis 2:2, pages 70-81.
Crossref
Crossref
Adam L. Halberstadt & David E. Nichols. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
621
636
.
Ly Binh T.Richard F. Clark & Saralyn R. Williams. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice
2010
2018
.
Anna M. S. Kindlundh-Högberg, Chris Pickering, Grzegorz Wicher, David Hobér, Helgi B. Schiöth & Åsa Fex Svenningsen. (2009) MDMA (Ecstasy) Decreases the Number of Neurons and Stem Cells in Embryonic Cortical Cultures. Cellular and Molecular Neurobiology 30:1, pages 13-21.
Crossref
Crossref
Mireille M. Meyerhoefer. 2011. Addiction Medicine. Addiction Medicine
585
602
.
Martin A. Javors, Thomas S. King, Brett C. Ginsburg & Lisa R. Gerak. 2011. Addiction Medicine. Addiction Medicine
283
331
.
Manoranjan S. D’Souza & Athina Markou. 2010. Behavioral Neuroscience of Drug Addiction. Behavioral Neuroscience of Drug Addiction
119
178
.
Neeltje Vogels, Tibor M. Brunt, Sander Rigter, Peter Van Dijk, Hylke Vervaeke & Raymond J. M. Niesink. (2009) Content of ecstasy in the Netherlands: 1993–2008. Addiction 104:12, pages 2057-2066.
Crossref
Crossref
F. HaslerE. Studerus, K. Lindner, S. Ludewig & FX Vollenweider. (2008) Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. Journal of Psychopharmacology 23:8, pages 923-935.
Crossref
Crossref
Linda B. Cottler, Kit Sang Leung & Arbi Ben Abdallah. (2009) Test–re‐test reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross‐national study. Addiction 104:10, pages 1679-1690.
Crossref
Crossref
Markus R. Meyer, Frank T. Peters & Hans H. Maurer. (2009) Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicology Letters 190:1, pages 54-60.
Crossref
Crossref
Fernando Caudevilla Gálligo, Paloma González Tardón & Carmen Fenoll Brotons. (2009) Drogas de síntesis: novedades. FMC - Formación Médica Continuada en Atención Primaria 16:7, pages 383-392.
Crossref
Crossref
Torsten Passie. 2009. Welche Sprache hat die Psyche?. Welche Sprache hat die Psyche?
257
282
.
Ximena Perfetti, Brian O'Mathúna, Nieves Pizarro, Elisabet Cuyàs, Olha Khymenets, Bruno Almeida, Manuela Pellegrini, Simona Pichini, Serrine S. Lau, Terrence J. Monks, Magí Farré, Jose Antonio Pascual, Jesús Joglar & Rafael de la Torre. (2009) Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion. Drug Metabolism and Disposition 37:7, pages 1448-1455.
Crossref
Crossref
Markus R. Meyer & Hans H. Maurer. (2009)
Enantioselectivity in the Methylation of the Catecholic Phase I Metabolites of Methylenedioxy Designer Drugs and Their Capability To Inhibit Catechol-
O
-methyltransferase-Catalyzed Dopamine 3-Methylation
. Chemical Research in Toxicology 22:6, pages 1205-1211.
Crossref
Crossref
William E. Fantegrossi, Naoki Murai, Brian Ó. Mathúna, Nieves Pizarro & Rafael de la Torre. (2009) Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Its Enantiomers in Mice: Pharmacokinetic Considerations. Journal of Pharmacology and Experimental Therapeutics 329:3, pages 1006-1015.
Crossref
Crossref
Markus R. Meyer, Frank T. Peters & Hans H. Maurer. (2009) Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers. Biochemical Pharmacology 77:11, pages 1725-1734.
Crossref
Crossref
Sylvia K. Shenouda, Kurt J. Varner, Felix Carvalho & Pamela A. Lucchesi. (2009) Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes. Cardiovascular Toxicology 9:1, pages 30-38.
Crossref
Crossref
Christina Goulding, Avi Shankar, Richard Elliott & Robin Canniford. (2009) The Marketplace Management of Illicit Pleasure. Journal of Consumer Research 35:5, pages 759-771.
Crossref
Crossref
Wei Cheng, Ran Lv & Hong-Jun Zhu. (2008) 1-(1,3-Benzodioxol-5-yl)butan-1-one. Acta Crystallographica Section E Structure Reports Online 65:1, pages o179-o179.
Crossref
Crossref
Takuji Shoda, Kiyoshi Fukuhara, Yukihiro Goda & Haruhiro Okuda. (2009) 4-Hydroxy-3-methoxymethamphetamine Glucuronide as a Phase II Metabolite of 3,4-Methylenedioxymethamphetamine: Enzyme-Assisted Synthesis and Involvement of Human Hepatic Uridine 5′-Diphosphate-Glucuronosyltransferase 2B15 in the Glucuronidation. CHEMICAL & PHARMACEUTICAL BULLETIN 57:5, pages 472-475.
Crossref
Crossref
Displaying 200 of 317 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list